相关内容
下载与本次活动及主题相关的内容。
The 11th Biologics Festival India 2027 is a major life sciences conference focused on advancing vaccine and biologics development for emerging markets.

The 11th Biologics Festival India 2027 is the premier venue for the life sciences community to bridge the gap between R&D, process development, and bioprocessing of vaccines and biologics for emerging markets. This event aims to unite all stakeholders from India and Asia to discuss regulatory issues, new product innovations, the latest developments in manufacturing and operations, supply chain logistics, and optimal go-to-market strategies.
.webp)

访问活动页面查看更多内容。
访问奖项页面查看更多内容。
查看核心主题
Biologics Festival India 2027
立即注册以预留您的席位。
我们精选的专家将分享关于这一动态领域最新趋势、挑战和发展的见解。与这些极具影响力的思想领袖共同参与独特的讨论,了解前沿科学发现,并探索生物制药的未来。


.webp)
.webp)
Biography - A leader with 20+ years of experience in aseptic manufacturing and quality excellence, inspiring innovation and continuous improvement in the pharmaceutical industry.
I bring over 20 years of experience in the biopharmaceutical and pharmaceutical industry, specializing in Quality functions, Commissioning & Qualification, and Formulation Development. My career has focused on aseptic manufacturing of bulk and final fill operations, where I have successfully led the setup of new facilities, managed regulatory audits, and driven technology transfers across diverse dosage forms. I am passionate about operational excellence, digital innovation, and continuous improvement—transforming complex challenges into opportunities for growth. Over the years, I have guided teams through critical projects that strengthened compliance, enhanced efficiency, and elevated standards in manufacturing.
As I share my journey, my goal is not only to highlight the importance of quality and innovation but also to inspire the next generation of professionals to embrace excellence, adaptability, and a forward-looking mindset in shaping the future of our industry.
.webp)
.webp)
Dr Neera Gupta, VP & Head- Clinical Development & Medical Affairs at Immuneel Therapeutics Ltd, Bangalore. She holds an MD in Pharmacology and a residency in Oncology, bringing over 23 plus years of extensive experience spanning Oncology , Haematology, Immunology, Endocrinology and Critical Care.
Her areas of expertise include Biologics, Biosimilars, Clinical Research , Medical Affairs and Medical Education. In her past experiences she has been associated with Intas, Wockhardt, GlaxoSmithKline , Novo Nordisk and Biocon Biologics Ltd.
She is a medical strategy leader driving patient centric innovation expanding treatment access, policy shaping, accelerating clinical trial enrolment and academic collaborations.
She has been invited speaker at various forums , has 20+ product launches and several publications to her credit.


Rakesh Kumar Sinha is Senior Vice President at Biological E. Limited, bringing over 33 years of leadership experience in pharmaceutical and vaccine manufacturing. He currently leads drug product manufacturing for one of the world's largest vaccine production operations, overseeing large-scale manufacturing, operational excellence, quality, and strategic transformation. Throughout his career, he has held senior leadership roles across leading pharmaceutical organisations, successfully driving greenfield projects, site operations, manufacturing scale-up, and continuous improvement initiatives. An advocate of digital transformation and operational excellence, Rakesh is passionate about building high-performing teams and advancing innovative manufacturing practices that deliver safe, high-quality, and affordable vaccines to patients worldwide. He holds a Bachelor's degree in Pharmacy from IIT (BHU), Varanasi, and a Master's degree in Pharmaceutical Operations & Management from BITS Pilani.
.webp)
.webp)
Pallavi Trivedi, RAC is Head - Regulatory Affairs CMC & Devices, Diabetes & obesity at Novo Nordisk, with more than 20 years of experience across the biopharmaceutical and biotechnology industries. She specializes in global CMC and device regulatory strategy, lifecycle management, post-approval change management, and enabling regulatory pathways that support product launches, supply continuity, and portfolio value optimisation.
A recognised regulatory thought leader, Pallavi has over a decade of experience building and leading global teams, influencing cross-functional stakeholders, and translating complex regulatory challenges into practical business solutions. She is an active contributor to the regulatory profession through the Regulatory Affairs Professionals Society (RAPS), served its Board of Editors and European Council, and is a author of multiple regulatory publications and reference books.


Mr. Vipul Doshi has been in pharmaceutical Industry from more than four decades with diverse leadership and operational expertise across development, manufacturing, R&D, GXP quality assurance (QA) and manufacturing operations (parenterals, solid dosage forms, biotechnology, transdermal, biologics and vaccines).
He has been leading the Quality and Regulatory affairs function in the Pharmaceutical Companies of high credentials. Throughout his career he has been providing passionate global leadership and pioneered in guiding the companies to meet the Global Regulatory, Quality Standards and Compliance requirements.
He has been a Great Contributor in developing and implementing Quality attributes and Culture of Excellence based upon a set of core values and ethical practices, which integrate and improve business operations and enhance the compliance within the Organization.
请为您的机构选择相应的门票。
*参会者必须根据正确的类别购买门票。
生物制药类门票 仅限受雇于制药或生物制药公司的专业人士购买,此类公司需从事治疗性药物产品的开发、拥有或商业化业务,包括拥有涵盖发现、开发、临床或商业化阶段内部药物管线的机构。此类别适用于主营业务为药物产品开发或制造的公司,不适用于提供赋能技术、设备、平台或服务的公司。
服务、解决方案及技术提供商门票 适用于所有为制药和生物制药行业提供服务、平台、技术、设备、咨询、制造服务或商业解决方案的机构。这包括但不限于 CRO、CDMO、技术和设备供应商、顾问、供应商及解决方案提供商,无论其科学或技术重点为何。
重要提示
所有注册信息均经过审核,以确保分类正确。购买错误的门票不能保证您能进入活动现场。IMAPAC 保留拒绝入场、重新分类注册信息以及针对正确参会所需差价开具发票的最终决定权。对于因选择不当类别而购买的错误门票,在任何情况下均不予退款,包括注册者选择不升级门票或不出席活动的情况。
Early Bird Rate : SGD 1,495
Use discount code: EARLYBIRD
(Valid until 3rd October 2026)
Registration Open Rate : SGD 1,695
Use discount code: REGISTRATIONOPEN
(Valid until 5th December 2026)
Standard Rate : SGD 1,895
Use discount code: STANDARD
(Valid until 6th February 2026)
Final Call Rate : SGD 2,095
Applicable to company profiles (headquartered within the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Early Bird Rate : SGD 1,995
Use discount code: EARLYBIRD
(Valid until 3rd October 2026)
Registration Open Rate : SGD 2,195
Use discount code: REGISTRATIONOPEN
(Valid until 5th December 2026)
Standard Rate : SGD 2,395
Use discount code: STANDARD
(Valid until 6th February 2026)
Final Call Rate : SGD 2,595
Applicable to company profiles (headquartered outside of the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Early Bird Rate : SGD 2,995
Use discount code: EARLYBIRD
(Valid until 3rd October 2026)
Registration Open Rate : SGD 3,195
Use discount code: REGISTRATIONOPEN
(Valid until 5th December 2026)
Standard Rate : SGD 3,395
Use discount code: STANDARD
(Valid until 6th February 2026)
Final Call Rate : SGD 3,595
Applicable to company profiles:
Job Profiles: Business Development, Marketing, and Sales
联系 IMAPAC,了解我们的赞助流程、费用及更多信息。
访问活动页面以查看更多内容。
下载与本次活动及主题相关的内容。
如需了解活动动态(包括日期、地点和议程),请订阅我们的官方社交媒体渠道,以获取实时更新和公告。
本次会议将提供全面的学习体验,涵盖充满活力的生物制药行业的各个方面,确保参会者获得宝贵的见解和知识。
我们致力于确保所有参会者的安全与健康。我们将根据当地的卫生准则和法规实施严格的安全措施。具体的安全措施将在活动临近时公布,以确保其符合最新的健康建议。请放心,您的安全是我们的首要任务。
我们欢迎提交演讲申请。如果您有兴趣在活动中发言,请访问我们网站上的相关页面,查看提交指南和截止日期。
我们的活动旨在满足生物制药行业内各类专业人士的需求,包括研究人员、科学家、高管、监管专家以及从事药物开发和制造的专业人士。
参会者可以从行业专家那里获得深刻见解,与同行建立联系,并及时了解生物制药领域的最新趋势和创新。
是的,我们在活动期间安排了社交环节、研讨会和社交活动,旨在促进参会者之间的联系与合作。
我们为企业和组织提供赞助及参展机会。
如需注册参加活动,请点击页面上的任意“注册”按钮开始操作。您可以在其中找到详细的注册说明和选项,包括价格和截止日期。
千万不要错过这些独特的社交、演讲和赞助机会。
Scan this QR code using WeChat or WeCom to connect with our team.
JUNMIN PENG
IMAPAC